In previously published studies which reported that only mutant TP53/TRP53 expressing cells were sensitive to APR-246 [54, 55], the wt or mutant TP53 expressing human cancer cell lines tested were derived from different tumours and thus had distinct genetic backgrounds with different oncogenic driver mutations. This evidence concerns the gene TP53 and cancer.